Once-weekly GLP-1 medications like semaglutide (Ozempic) and dulaglutide (Trulicity) offer greater convenience with less frequent injections, while once-daily options like liraglutide (Victoza) may provide more consistent day-to-day effects
Clinical trials have shown promising results in terms of blood sugar (HbA1C) reduction and supporting weight loss compared to other treatments
In a 2018 study published in Current Pharmaceutical Design , researchers compared the effectiveness of BPC-157 to that of various standard peptidergic angiogenic growth factors (EGF, FGF, and VEGF) and numerous carriers for treating gastrointestinal ulcer healing and tendon, ligament, muscle, and bone healing
NICE and MHRA guidance recommend monitoring for gastrointestinal side effects and reporting adverse reactions through the Yellow Card scheme
AOD 9604 timing AOD 9604 must be administered in a fasted state
That same 10-unit injection from a 2.5mg/mL vial gives you only 0.25 mg